LeMaitre Vascular LMAT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $62.4M+8.1% | $57.73M+8.2% | $53.34M+13.2% | $47.12M+4.3% | $45.16M+2.6% | ||
| $10.49M+0.7% | $10.42M+1.8% | $10.23M+1.9% | $10.04M+2.7% | $9.78M+1.8% | ||
| $7.87M+0.6% | $7.83M+4.8% | $7.47M+1.8% | $7.34M+4.8% | $7M+6.6% | ||
| $87.31M+7.5% | $81.25M+10.9% | $73.28M+24.7% | $58.76M+22.2% | $48.09M+9.0% | ||
| $8.18M+20.6% | $6.78M-3.8% | $7.05M+9.5% | $6.44M-7.7% | $6.98M+0.2% | ||
| $1.9M+0.1% | $1.9M+1,899% | $95K0.0% | $95K+116% | $44K— | ||
| -$73.74M-13.6% | -$64.94M+70.7% | -$222.01M-7.0% | -$207.43M-2.6% | -$202.08M-1.0% | ||
| $19.3M+6.6% | $18.11M+5.5% | $17.17M+5.8% | $16.23M+6.1% | $15.31M+6.5% | ||
| $1.68M-7.7% | $1.82M-7.0% | $1.96M-0.1% | $1.96M-0.2% | $1.96M+14.1% | ||
| -$12.52M+13.9% | -$14.54M-109% | $153.13M+0.1% | $152.93M+0.1% | $152.82M-3.3% | ||
| $1.51M-42.6% | $2.63M-41.4% | $4.49M-8.5% | $4.91M+491% | -$1.26M-194% | ||
| $79.12M+6.2% | $74.47M+12.4% | $66.23M+26.6% | $52.32M+27.2% | $41.12M+10.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does LeMaitre Vascular's cash flow data come from?
- Every line is extracted from LeMaitre Vascular's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.